BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 6464831)

  • 1. The neuropharmacological effects of electroconvulsive shock and their relationship to the therapeutic effect of electroconvulsive therapy in depression.
    Grahame-Smith DG
    Adv Biochem Psychopharmacol; 1984; 39():327-43. PubMed ID: 6464831
    [No Abstract]   [Full Text] [Related]  

  • 2. A role of some central neurotransmitter systems in the mechanism of electroconvulsive shock action.
    Kleinrok Z; Wielosz M
    Pol J Pharmacol Pharm; 1985; 37(6):745-52. PubMed ID: 3008135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of electroconvulsive shock on monoaminergic systems in the rat brain. Thesis.
    Wielosz M
    Pol J Pharmacol Pharm; 1983; 35(2):127-30. PubMed ID: 6684770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors and the mechanism of action of ECT.
    Lerer B; Belmaker RH
    Biol Psychiatry; 1982 Apr; 17(4):497-511. PubMed ID: 6282347
    [No Abstract]   [Full Text] [Related]  

  • 5. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The development of our understanding of the mechanism of action of antidepressant drugs.
    Vetulani J
    Pol J Pharmacol Pharm; 1991; 43(4):323-38. PubMed ID: 1811223
    [No Abstract]   [Full Text] [Related]  

  • 7. [Neurochemical aspects of the emotional reactivity and motor activity of rats in new circumstances].
    Kulagin DA; Bolondinskiĭ VK
    Usp Fiziol Nauk; 1986; 17(1):92-109. PubMed ID: 2420084
    [No Abstract]   [Full Text] [Related]  

  • 8. The involvement of serotonin and noradrenaline in the psychopathological processes of stress and depression: animal models and the effect of antidepressant drugs.
    Płaźnik A; Kostowski W
    Pol J Pharmacol Pharm; 1991; 43(4):301-22. PubMed ID: 1811222
    [No Abstract]   [Full Text] [Related]  

  • 9. Interactions of 5-hydroxytryptamine and gamma-aminobutyric acid with dopamine.
    Pycock CJ; Horton RW; Carter CJ
    Adv Biochem Psychopharmacol; 1978; 19():323-41. PubMed ID: 358783
    [No Abstract]   [Full Text] [Related]  

  • 10. [Functional role of transmitter systems in the brain].
    Guldberg HC
    Tidsskr Nor Laegeforen; 1973 Jun; 93(17):1305-9. PubMed ID: 4148047
    [No Abstract]   [Full Text] [Related]  

  • 11. Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.
    Costain DW; Cowen PJ; Gelder MG; Grahame-Smith DG
    Lancet; 1982 Aug; 2(8295):400-4. PubMed ID: 6124803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interrelationship between brain noradrenergic and dopaminergic neuronal systems in regulating animal behavior: possible clinical implications.
    Plaźnik A; Kostowski W
    Psychopharmacol Bull; 1983; 19(1):5-11. PubMed ID: 6338550
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of duloxetine, an antidepressant drug candidate, on concentrations of monoamines and their metabolites in rats and mice.
    Fuller RW; Hemrick-Luecke SK; Snoddy HD
    J Pharmacol Exp Ther; 1994 Apr; 269(1):132-6. PubMed ID: 7513356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neurochemistry of behavior.
    Panksepp J
    Annu Rev Psychol; 1986; 37():77-107. PubMed ID: 3963784
    [No Abstract]   [Full Text] [Related]  

  • 15. Brain noradrenergic neurons, their interactions and role in the action of antidepressive drugs.
    Kostowski W
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):29-36. PubMed ID: 7124417
    [No Abstract]   [Full Text] [Related]  

  • 16. The antidepressant-like effect of Hypericum caprifoliatum Cham & Schlecht (Guttiferae) on forced swimming test results from an inhibition of neuronal monoamine uptake.
    Viana A; do Rego JC; von Poser G; Ferraz A; Heckler AP; Costentin J; Kuze Rates SM
    Neuropharmacology; 2005 Dec; 49(7):1042-52. PubMed ID: 16040063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal glucocorticoid binding: serotoninergic regulation and drug effects; relevance to behavioral-endocrine activities and depression.
    Angelucci L; Patacchioli FR; Scaccianoce S; Martucci E; Capasso M
    Ann Ist Super Sanita; 1982; 18(1):35-9. PubMed ID: 6892091
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroscience. Vehicles of inactivation.
    Snyder SH
    Nature; 1991 Nov; 354(6350):187. PubMed ID: 1683684
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of adjuvant drug therapy following successful electroconvulsive therapy for therapy-resistant depression is still disappointing].
    Leentjens AF; van den Broek WW; Birkenhäger TK; Moleman P; Bruijn JA
    Ned Tijdschr Geneeskd; 1996 Feb; 140(5):241-3. PubMed ID: 8643129
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurobiological correlates of the antidepressant action of electroconvulsive therapy.
    Mann JJ
    J ECT; 1998 Sep; 14(3):172-80. PubMed ID: 9773356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.